BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
196 hedge funds and large institutions have $996M invested in bluebird bio in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-35
Holders Change %
-15.15%
% of All Funds
3.44%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
63
Reduced
60
Closed
58
Calls
$9.13M
Puts
$17.8M
Net Calls
-$8.64M
Net Calls Change
-$2.12M
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$47.8M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$85.4M |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$15.3M |
| 4 |
AC
4
Armistice Capital
New York
|
$47.2M |
| 5 |
SC
5
Sessa Capital
New York
|
$35.1M |
